Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study
Abhijit Sen, Konstantinos K Tsilidis, Naomi E Allen, Sabina Rinaldi, Paul N Appleby, Martin Almquist, Julie A Schmidt, Christina C Dahm, Kim Overvad, Anne Tjonneland, Agnetha L Rostgaard-Hansen, Francoise Clavel-Chapelon, Laura Baglietto, Marie-Christine Boutron-Ruault, Tilman Kuehn, Verena A Katze, Heiner Boeing, Antonia Trichopoulou, Christos Tsironis, Pagona Lagiou Show all
British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2015
Awarded by ISCIII RETIC (Spain)
Awarded by Cancer Research UK
Awarded by Medical Research Council
Awarded by National Institute for Health Research
The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by the Danish Cancer Society (Denmark); the Ligue Contre le Cancer, Societe 3M, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (France); the Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); the Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); the Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF); the Statistics Netherlands (The Netherlands); the Norwegian Cancer Society (Norway); the Health Research Fund (FIS), Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020) (Spain); the Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten, Fundacion Federico SA (Sweden); the Cancer Research UK, Medical Research Council (United Kingdom).